1 gene regulates pain, learning and memory
|
|
In 2002, a group of scientists at the University of Toronto was able to identify a gene which they dubbed DREAM (downstream regulatory element antagonistic modulator). The gene’s function was highly interesting: it obviously served as a key regulator in the perception of pain. Mice who lacked the gene showed clear signs of markedly reduced sensitivity to all kinds of pain, whether chronic or acute. Otherwise, the mice appeared perfectly normal.
The work leading to these findings was carried out in the lab of Josef Penninger, then principal investigator at the Amgen Institute in Toronto. The publication describing the gene’s function was received with great interest (Cell, Vol. 108, 31-43, 11.1.2002) and DREAM was subsequently termed the “Master-Gene of pain perception”.
Josef Penninger, meanwhile scientific director of IMBA, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna, continued to wonder what other surprises DREAM might have in store. In a collaborative effort with neurobiologists from the University Pablo de Olivade (Seville) he devised experiments to follow up on the previous findings. A team of scientists under Ángel Manuel Carrión subjected DREAM-less mice to numerous neurological tests and analyzed their memory skills. The results were striking: without DREAM, mice were able to learn faster and remember better. Fascinatingly, the brains of aged mice (18 months) showed learning capacities similar to those of very young mice.
Thus, DREAM turns out to be a genetic candidate for explaining old age dementia. Even a causal connection to Alzheimer’s disease seems plausible. Studies published in mid 2008 suggest that the devastating condition may be related to Calcium regulation gone awry. The accumulation of amyloid plaques in brain cells, usually blamed for Alzheimer’s, might be a consequence of the Calcium-imbalance rather than the culprit for the disease.
And Calcium regulation is also responsible for tuning the activity of the DREAM-gene. Calcium homeostasis may thus be the link between pain perception, learning and memory. This is supported by observations of patients suffering from chronic pain: very often their ability to memorize is strikingly reduced and they need a lot more time to learn than individuals without pain.
“It is absolutely fascinating that we found a gene which at the same time regulates pain, learning and old age memory function”, says Josef Penninger, “and it is of great interest to the millions of people suffering from chronic pain that we follow up on these results.”
###
The paper „Lack of DREAM protein enhances learning and memory and slows brain aging” by Fontán-Lozano et al. has been published in the current issue of the Journal Current Biology [Curr Biol. 2009 Jan 13;19(1):54-60].
IMBA
IMBA, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences, combines basic and applied research in the area of biomedicine. Interdisciplinary research groups work towards understanding the fundamental molecular underpinnings of normal and pathological behavior. The ultimate aim is to translate this knowledge into novel approaches for diagnosis, prevention and therapy of diseases. IMBA is financed by the City of Vienna and the Austrian Government.
IMP-IMBA Research Center
The Research Institute of Molecular Pathology (IMP), established in 1988 by Boehringer Ingelheim, and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), which went into operation in 2003, have agreed on a close research collaboration. Under the name “IMP-IMBA Research Center”, the two institutes share most of the administrative and scientific infrastructure. Together, IMBA and IMP employ over 400 people from 30 different nations. Both institutes are members of the “Campus Vienna Biocenter”.
Contact:
Dr. Heidemarie Hurtl, IMBA Communications
Tel. +43 1 79730-3625
Mobile: +43 (0)664 8247910
.(JavaScript must be enabled to view this email address)
Scientific Contact:
Prof. Josef Penninger
.(JavaScript must be enabled to view this email address)
Contact: Dr. Heidemarie Hurtl
.(JavaScript must be enabled to view this email address)
43-179-730-3625
Research Institute of Molecular Pathology
Print Version
Tell-a-Friend comments powered by Disqus
